NSE - Delayed Quote INR

Aster DM Healthcare Limited (ASTERDM.NS)

Compare
346.85 -5.35 (-1.52%)
At close: 3:30 PM GMT+5:30
Loading Chart for ASTERDM.NS
DELL
  • Previous Close 352.20
  • Open 353.25
  • Bid --
  • Ask --
  • Day's Range 342.20 - 353.95
  • 52 Week Range 279.50 - 558.00
  • Volume 2,185,407
  • Avg. Volume 2,830,213
  • Market Cap (intraday) 172.611B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 96.62
  • EPS (TTM) 3.59
  • Earnings Date Aug 12, 2024 - Aug 16, 2024
  • Forward Dividend & Yield 4.00 (1.14%)
  • Ex-Dividend Date Aug 21, 2024
  • 1y Target Est 410.83

Aster DM Healthcare Limited provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail pharmacies and optical outlets. It also offers healthcare consultancy and other services. The company was founded in 1987 and is headquartered in Dubai, United Arab Emirates.

www.asterdmhealthcare.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ASTERDM.NS

View More

Performance Overview: ASTERDM.NS

Trailing total returns as of 6/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ASTERDM.NS
9.90%
S&P BSE SENSEX
9.69%

1-Year Return

ASTERDM.NS
60.82%
S&P BSE SENSEX
25.84%

3-Year Return

ASTERDM.NS
186.50%
S&P BSE SENSEX
49.73%

5-Year Return

ASTERDM.NS
275.00%
S&P BSE SENSEX
100.15%

Compare To: ASTERDM.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ASTERDM.NS

View More

Valuation Measures

Annual
As of 6/26/2024
  • Market Cap

    175.22B

  • Enterprise Value

    187.50B

  • Trailing P/E

    97.83

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.73

  • Price/Book (mrq)

    3.84

  • Enterprise Value/Revenue

    5.07

  • Enterprise Value/EBITDA

    13.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.49%

  • Return on Assets (ttm)

    1.36%

  • Return on Equity (ttm)

    4.14%

  • Revenue (ttm)

    36.99B

  • Net Income Avi to Common (ttm)

    1.22B

  • Diluted EPS (ttm)

    3.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.16B

  • Total Debt/Equity (mrq)

    27.51%

  • Levered Free Cash Flow (ttm)

    -15.47B

Research Analysis: ASTERDM.NS

View More

Company Insights: ASTERDM.NS

Research Reports: ASTERDM.NS

View More

People Also Watch